ACCESSWIRE
23 Feb 2021, 09:25 GMT+10
LONDON, UK / ACCESSWIRE / February 22, 2021 / Following the safety and tolerability data from the two Phase I trials in healthy volunteers, INM-755 is moving forward into a Phase II (755-201-EB) trial in up to 20 epidermolysis bullosa (EB) patients with an anticipated treatment duration of 28 days. Regulatory applications are expected to be filed in several countries in Q2 CY21 with enrolment to begin in the second half of the calendar year. Also, the formulation for INM-088 has been finalized with IND-enabling toxicology studies expected to begin in CY21 and filings for human clinical trials to begin in H1 CY22.
We have adjusted our valuation from US$233m or US$33.34 per basic share to US$236m or US$29.27 per basic share. The total valuation rose due to higher net cash following a financing, while the per-share value decreased due to a higher number of shares outstanding.
Click here to view the full report or here to sign up to receive research as it is published.
All reports published by Edison are available to download free of charge from its website www.edisongroup.com
About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutionffices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in ths, family oe darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.
Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.
Edison is authorised and regulated by the Financial Conduct Authority.
Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.
For more information, please contact Edison:
Maxim Jacobs, +1 646 653 7027, healthcare@edisongroup.com
Nathaniel Calloway, +1 646 653 7036, healthcare@edisongroup.com
Learn more at www.edisongroup.com and connect with Edison on:
LinkedIn https://www.linkedin.com/company/edison-group-/
Twitter www.twitter.com/Edison_Inv_Res
YouTube www.youtube.com/edisonitv
SOURCE: Edison Investment Research Limited
Get a daily dose of Atlanta Leader news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Atlanta Leader.
More InformationWASHINGTON D.C.: In a bid to create a much greater supply of Coronavirus vaccines, the White House has announced that ...
AUSTIN, Texas: Texas Governor Greg Abbott announced that beginning next week face masks will no longer be needed to be ...
WASHINGTON D.C.: President Joe Biden says he expects there to be enough vaccinations for all Americans by the end of ...
HOLTVILLE, California: An overloaded SUV carrying as many as 25 passengers slammed into a semi-truck in California on Monday, killing ...
ALBANY, New York: New York's new coronavirus-period dance rules will allow some dancing at parties. The state said that when ...
WASHINGTON D.C.: Looking beyond the $1.9 trillion COVID-19 relief bill, President Joe Biden and other lawmakers are establishing the foundations ...
Subscriptions to Walt Disney Company's Disney+ streaming service surpassed initial estimates, primarily owing to adults from households with no children ...
DUBLIN, Ireland - The Bank of Ireland plans to close some 100 branches, as customers increasingly perform banking transactions online.Bank ...
SYDNEY, NSW, Australia - Another spike in bond yields, and oil prices sent shares in Asia sharply lower on Friday, ...
CARSON CITY, Nevada: Nevada Governor Steve Sisolak has proposed allowing technology companies specializing in blockchain technology to develop "Innovation Zones" ...
Walmart has hired two former Goldman Sachs bankers to help run its new and unnamed fintech venture.Walmart hired Omer Ismail, ...
NEW YORK, New York - U.S. stocks fell sharply Thursday, spurred on by rising bond yields. "There is a fork ...